D
Nuvalent, Inc. NUVL
$106.52 $1.561.49% NASDAQ
Recommendation
Prev Close
$104.96
Volume
168,547
Avg Vol (90D)
538,985
Market Cap
$8.15B
Dividend & Yield
--
52-Week Range
$55.54 - $112.88
P/E (TTM)
--
EPS (TTM)
-$5.32
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
American Century Companies Inc. Boosts Holdings in Nuvalent, Inc. $NUVL
12/1/2025 - MarketBeat
Nuvalent (NASDAQ:NUVL) Director Sells $639,814.50 in Stock
11/27/2025 - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Sells 14,688 Shares of Nuvalent, Inc. $NUVL
11/26/2025 - MarketBeat
Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/26/2025 - GuruFocus
Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/26/2025 - PR Newswire
Nuvalent (NASDAQ:NUVL) Director Sells $70,871,262.56 in Stock
11/26/2025 - MarketBeat
Nuvalent (NASDAQ:NUVL) Earns Buy Rating from Analysts at Truist Financial
11/25/2025 - MarketBeat
James Flynn Sells 742,574 Shares of Nuvalent (NASDAQ:NUVL) Stock
11/25/2025 - MarketBeat
Ensign Peak Advisors Inc Sells 33,576 Shares of Nuvalent, Inc. $NUVL
11/25/2025 - MarketBeat
Nuvalent Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters ...
11/24/2025 - GuruFocus
Nuvalent Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares from Selling Stockholders
11/24/2025 - PR Newswire
Truist Securities Initiates Coverage on Nuvalent (NUVL) with a Buy Rating NUVL Stock News
11/24/2025 - GuruFocus
Nuvalent initiated with bullish view at Truist, here's why
11/24/2025 - The Fly
Nuvalent, Inc. $NUVL Shares Purchased by Geode Capital Management LLC
11/24/2025 - MarketBeat
What is Wedbush's Estimate for Nuvalent FY2027 Earnings?
11/24/2025 - MarketBeat
Nuvalent (NUVL): Assessing Valuation Following FDA Filing Acceptance and Positive Clinical Updates
11/23/2025 - Simply Wall St
Intech Investment Management LLC Boosts Stock Position in Nuvalent, Inc. $NUVL
11/23/2025 - MarketBeat
Wedbush Has Optimistic Outlook of Nuvalent FY2027 Earnings
11/21/2025 - MarketBeat
Leerink Partnrs Reduces Earnings Estimates for Nuvalent
11/21/2025 - MarketBeat
Nuvalent (NASDAQ:NUVL) CFO Sells $76,005.54 in Stock
11/21/2025 - MarketBeat
Alexandra Balcom Sells 20,000 Shares of Nuvalent (NASDAQ:NUVL) Stock
11/21/2025 - MarketBeat
Deborah Ann Miller Sells 24,200 Shares of Nuvalent (NASDAQ:NUVL) Stock
11/21/2025 - MarketBeat
Nuvalent (NASDAQ:NUVL) CFO Alexandra Balcom Sells 729 Shares of Stock
11/20/2025 - Ticker Report
Insider Selling: Nuvalent (NASDAQ:NUVL) CFO Sells 729 Shares of Stock
11/20/2025 - MarketBeat
Nuvalent (NASDAQ:NUVL) Sees Large Volume Increase on Analyst Upgrade
11/20/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$398.38M
Net Income (TTM)
-$381.44M
Balance Sheet
Total Assets (Q)
$979.91M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$134.51M
Book Value Per Share (Q)
$11.70
Cash Flow
Cash from Operations (TTM)
-$263.88M
Cash from Investing (TTM)
-$13.18M
Cash from Financing (TTM)
$23.57M
Net Change in Cash (TTM)
-$253.49M
Filings
Filing Date
Thursday, October 30, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Loading...
Beta
1.05
7-Day Total Return
0.22%
30-Day Total Return
9.19%
60-Day Total Return
34.78%
90-Day Total Return
29.50%
Year to Date Total Return
32.65%
1-Year Total Return
11.99%
2-Year Total Return
58.00%
3-Year Total Return
210.63%
5-Year Total Return
--
52-week Low
Apr 09, 2025 - $55.54
52-week High
Nov 20, 2025 - $112.88
Valuation
Market Cap
$8.15B - Mid Cap
Enterprise Value
$7.21B
Price/Sales (TTM)
--
Price/Book (Q)
8.97
Dividends and Shares
Shares Outstanding
72.14
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.nuvalent.com
Phone Number
857 357 7000
Address
One Broadway
Cambridge, MA 02142
Country
United States
Year Founded
2017
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Its lead product candidates are NVL-520, a novel ROS1-selective... more
NASDAQ 12/03/2025 2:06PM Eastern Quotes delayed